KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Cash & Current Investments: 2016-2024

Historic Cash & Current Investments for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to $7.0 billion.

  • Moderna's Cash & Current Investments fell 34.41% to $4.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $22.6 billion, marking a year-over-year decrease of 30.32%. This contributed to the annual value of $7.0 billion for FY2024, which is 18.35% down from last year.
  • Latest data reveals that Moderna reported Cash & Current Investments of $7.0 billion as of FY2024, which was down 18.35% from $8.6 billion recorded in FY2023.
  • In the past 5 years, Moderna's Cash & Current Investments registered a high of $10.7 billion during FY2021, and its lowest value of $4.6 billion during FY2020.
  • In the last 3 years, Moderna's Cash & Current Investments had a median value of $8.6 billion in 2023 and averaged $8.5 billion.
  • In the last 5 years, Moderna's Cash & Current Investments surged by 317.72% in 2020 and then fell by 18.35% in 2024.
  • Over the past 5 years, Moderna's Cash & Current Investments (Yearly) stood at $4.6 billion in 2020, then surged by 132.79% to $10.7 billion in 2021, then fell by 7.69% to $9.9 billion in 2022, then decreased by 13.11% to $8.6 billion in 2023, then decreased by 18.35% to $7.0 billion in 2024.